Following the firm’s $1.75bn acquisition of radiopharmaceuticals company Mariana Oncology and the $745m deal with Ratio ...

The Texas Longhorns First Four March Madness matchup with Xavier is a huge game for the UT program. A loss to the Musketeers would most likely cost coach Rodney Terry his job. It would also be the ...

CNN's Jake Tapper refused to allow Secretary of Health and Human Services Robert F. Kennedy Jr. to pretend to be following ...

Following a second measles-related death in Texas, Robert F. | The HHS secretary called out the measles vaccines as "the most ...

The Texas Health Department has confirmed the second death linked to the ongoing measles outbreak in the U.S., prompting the new Health Secretary Robert F. Kennedy, Jr., to highlight the importance of ...

A robbery near a local Antlers grocery store turned into a shooting and pursuit that deputies say ended with a victim in the hospital and a ...

Meanwhile, shares of its pharmaceutical rival Merck (NYSE: MRK) have lagged, down 8% in the same period. Amgen shareholders are celebrating, but have you wondered which stock is cheaper right now?

The Texas Department of State Health Services announced on Tuesday that health officials there have identified 327 measles cases since late January amid an outbreak in the South Plains and ...

Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, the US drugmaker’s second recent foray into China for a novel medicine.

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor. In return for the ex-China rights to the drug, dubbed HRS-5346, Merck has ...

Merck was one of the pioneers of the cholesterol-lowering statins that launched in the 1980s and 1990s and changed medical practice. But it hasn’t been as successful with cholesterol medicines since ...